UnitedHealth Group Incorporated (ETR:UNH)
Germany
· Delayed Price · Currency is EUR 478.35
+0.35 (0.07%)
Mar 31, 2025, 2:35 PM CET
UnitedHealth Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Premiums & Annuity Revenue | 308,810 | 290,827 | 257,157 | 226,233 | 201,478 | Upgrade
|
| Total Interest & Dividend Income | 4,492 | 3,813 | 1,819 | 1,484 | 1,502 | Upgrade
|
| Gain (Loss) on Sale of Investments | 710 | 276 | 211 | 840 | - | Upgrade
|
| Non-Insurance Activities Revenue | 50,226 | 42,583 | 37,424 | 34,437 | 34,145 | Upgrade
|
| Other Revenue | 36,040 | 34,123 | 27,551 | 24,603 | 20,016 | Upgrade
|
| Total Revenue | 400,278 | 371,622 | 324,162 | 287,597 | 257,141 | Upgrade
|
| Revenue Growth (YoY) | 7.71% | 14.64% | 12.71% | 11.84% | 6.19% | Upgrade
|
| Policy Benefits | 264,185 | 241,894 | 210,842 | 186,911 | 159,396 | Upgrade
|
| Depreciation & Amortization | 4,099 | 3,972 | 3,400 | 3,103 | 2,891 | Upgrade
|
| Selling, General & Administrative | 53,013 | 54,628 | 47,782 | 42,579 | 41,704 | Upgrade
|
| Non-Insurance Activities Expense | 46,694 | 38,770 | 33,703 | 31,034 | 30,745 | Upgrade
|
| Total Operating Expenses | 367,991 | 339,264 | 295,727 | 263,627 | 234,736 | Upgrade
|
| Operating Income | 32,287 | 32,358 | 28,435 | 23,970 | 22,405 | Upgrade
|
| Interest Expense | -3,906 | -3,246 | -2,092 | -1,660 | -1,663 | Upgrade
|
| EBT Excluding Unusual Items | 28,381 | 29,112 | 26,343 | 22,310 | 20,742 | Upgrade
|
| Gain (Loss) on Sale of Assets | -8,310 | - | - | - | - | Upgrade
|
| Pretax Income | 20,071 | 29,112 | 26,343 | 22,310 | 20,742 | Upgrade
|
| Income Tax Expense | 4,829 | 5,968 | 5,704 | 4,578 | 4,973 | Upgrade
|
| Earnings From Continuing Ops. | 15,242 | 23,144 | 20,639 | 17,732 | 15,769 | Upgrade
|
| Minority Interest in Earnings | -837 | -763 | -519 | -447 | -366 | Upgrade
|
| Net Income | 14,405 | 22,381 | 20,120 | 17,285 | 15,403 | Upgrade
|
| Net Income to Common | 14,405 | 22,381 | 20,120 | 17,285 | 15,403 | Upgrade
|
| Net Income Growth | -35.64% | 11.24% | 16.40% | 12.22% | 11.30% | Upgrade
|
| Shares Outstanding (Basic) | 921 | 928 | 937 | 943 | 949 | Upgrade
|
| Shares Outstanding (Diluted) | 929 | 938 | 950 | 956 | 961 | Upgrade
|
| Shares Change (YoY) | -0.96% | -1.26% | -0.63% | -0.52% | -0.52% | Upgrade
|
| EPS (Basic) | 15.64 | 24.12 | 21.47 | 18.33 | 16.23 | Upgrade
|
| EPS (Diluted) | 15.51 | 23.86 | 21.18 | 18.08 | 16.03 | Upgrade
|
| EPS Growth | -35.00% | 12.65% | 17.15% | 12.79% | 11.86% | Upgrade
|
| Free Cash Flow | 20,705 | 25,682 | 23,404 | 19,889 | 20,123 | Upgrade
|
| Free Cash Flow Per Share | 22.29 | 27.38 | 24.64 | 20.80 | 20.94 | Upgrade
|
| Dividend Per Share | 8.180 | 7.290 | 6.400 | 5.600 | 4.830 | Upgrade
|
| Dividend Growth | 12.21% | 13.91% | 14.29% | 15.94% | 16.67% | Upgrade
|
| Operating Margin | 8.07% | 8.71% | 8.77% | 8.33% | 8.71% | Upgrade
|
| Profit Margin | 3.60% | 6.02% | 6.21% | 6.01% | 5.99% | Upgrade
|
| Free Cash Flow Margin | 5.17% | 6.91% | 7.22% | 6.92% | 7.83% | Upgrade
|
| EBITDA | 34,986 | 35,130 | 30,835 | 26,173 | 24,496 | Upgrade
|
| EBITDA Margin | 8.74% | 9.45% | 9.51% | 9.10% | 9.53% | Upgrade
|
| D&A For EBITDA | 2,699 | 2,772 | 2,400 | 2,203 | 2,091 | Upgrade
|
| EBIT | 32,287 | 32,358 | 28,435 | 23,970 | 22,405 | Upgrade
|
| EBIT Margin | 8.07% | 8.71% | 8.77% | 8.33% | 8.71% | Upgrade
|
| Effective Tax Rate | 24.06% | 20.50% | 21.65% | 20.52% | 23.98% | Upgrade
|
| Revenue as Reported | 400,278 | 371,622 | 324,162 | 287,597 | 257,141 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.